Publications by authors named "Scott Manetz"

Claim this Profile
I
Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studies.
Frank R Brennan, J Ryan Polli, Jean Sathish, Melissa Ramones, Babette Wolf, T Scott Manetz

MAbs· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight of Evidence: Is an Animal Study Warranted? Assessments for Carcinogenicity, Drug Abuse Liability, and Pediatric Safety.
Thulasi Ramani, Ronald L Wange, T Scott Manetz, Paul J Kruzich, Susan B Laffan

Int J Toxicol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein Aggregates in Inhaled Biologics: Challenges and Considerations.
Mariam Ibrahim, Ian Wallace, Saba Ghazvini, Scott Manetz, Ruth Cordoba-Rodriguez

J Pharm Sci· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful pregnancy in the setting of eosinophil depletion by benralizumab.
Scott Manetz, Irina Maric, Thomas Brown, Fei Li Kuang, Lauren Wetzler

J Allergy Clin Immunol Pract· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BSTP Review of 12 Case Studies Discussing the Challenges, Pathology, Immunogenicity, and Mechanisms of Inhaled Biologics.
A Peter Hall, Jeffrey S Tepper, Molly H Boyle, Maurice G Cary, Thierry G Flandre, Scott Manetz

Toxicol Pathol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of the Technical, Toxicological, and PKPD Considerations for Conducting Inhalation Toxicity Studies on Biologic Pharmaceuticals-The Outcome of a Cross-Industry Working Group Survey.
Alison Wolfreys, Jo Kilgour, Andrew D Allen, Sherri Dudal, Mark Freke, Scott Manetz

Toxicol Pathol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Periostin and Dipeptidyl Peptidase-4: Potential Biomarkers of Interleukin 13 Pathway Activation in Asthma and Allergy.
Claire Emson, Tuyet-Hang Pham, Scott Manetz, Paul Newbold

Immunol Allergy Clin North Am· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and analytical performance of a new ARCHITECT automated dipeptidyl peptidase-4 immunoassay.
Philip M Hemken, Nicolette M Jeanblanc, Tracey Rae, Susan E Brophy, Maria J Datwyler, T Scott Manetz

Pract Lab Med· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a new ARCHITECT automated periostin immunoassay.
Nicolette M Jeanblanc, Philip M Hemken, Maria J Datwyler, Susan E Brophy, T Scott Manetz

Clin Chim Acta· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical safety assessment of a recombinant plague vaccine (rF1V).
Jessica L Price, T Scott Manetz, Jeffry D Shearer, Robert V House

Int J Toxicol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical safety assessment of recombinant botulinum vaccine A/B (rBV A/B).
Jeffry D Shearer, T Scott Manetz, Robert V House

Vaccine· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biodistribution and toxicological safety of adenovirus type 5 and type 35 vectored vaccines against human immunodeficiency virus-1 (HIV-1), Ebola, or Marburg are similar despite differing adenovirus serotype vector, manufacturer's construct, or gene inserts.
Rebecca L Sheets, Judith Stein, Robert T Bailer, Richard A Koup, Charla Andrews, T Scott Manetz

J Immunotoxicol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical safety and biodistribution of Sindbis virus measles DNA vaccines administered as a single dose or followed by live attenuated measles vaccine in a heterologous prime-boost regimen.
Karina Ramirez, Eileen M Barry, Jeffrey Ulmer, Richard Stout, James Szabo, Scott Manetz

Hum Gene Ther· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicological safety evaluation of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar despite differing plasmid backbones or gene-inserts.
Rebecca L Sheets, Judith Stein, T Scott Manetz, Charla Andrews, Robert Bailer

Toxicol Sci· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biodistribution of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar, without integration, despite differing plasmid backbones or gene inserts.
Rebecca L Sheets, Judith Stein, T Scott Manetz, Chris Duffy, Martha Nason

Toxicol Sci· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scrub typhus vaccine candidate Kp r56 induces humoral and cellular immune responses in cynomolgus monkeys.
Suchismita Chattopadhyay, Ju Jiang, Teik-Chye Chan, T Scott Manetz, Chien-Chung Chao

Infect Immun· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis